Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04568616
Title Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) (NAOMI)
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dartmouth-Hitchcock Medical Center
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.